Skip to main content
Jeffrey Carpenter, MD, Vascular Surgery, Camden, NJ

JeffreyP.CarpenterMD

Vascular Surgery Camden, NJ

Professor and Chairman

Dr. Carpenter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Carpenter's full profile

Already have an account?

Summary

  • Dr. Jeffrey Carpenter is a vascular surgeon in Camden, NJ and is affiliated with Cooper University Health Care. He received his medical degree from Yale University School of Medicine and has been in practice 31 years. He is experienced in peripheral vascular disease, carotid disease, aortic surgery, endovascular surgery, and aortic disease.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Vascular Surgery, 1991 - 1992
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Surgery, 1986 - 1991
  • Yale School of Medicine
    Yale School of MedicineClass of 1986
  • Amherst College
    Amherst CollegeB.A., Major: Chemistry, Minor: Greek, Magna Cum Laude, 1977 - 1981

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2008 - 2025
  • PA State Medical License
    PA State Medical License 1987 - 2024
  • American Board of Surgery Vascular Surgery

Awards, Honors, & Recognition

  • Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
  • Philadelphia Magazine Castle Connolly, 2006-2014
  • America's Top Doctors Castle Connolly, 2006-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Late open conversion and explantation of abdominal aortic stent grafts  
    Brinster C, Carpenter JP, Journal of Vascular Surgery, 1/1/2011
  • A percutaneous aortic device for cerebral embolic protection during cardiovascular intervention  
    Carpenter JP, Carpenter JT, Tellez A, Webb JG, Yi GH, Granada JF, Journal of Vascular Surgery, 1/1/2011
  • Predictors of early and late mortality following open extent IV thoracoabdominal aortic aneurysm repair in a large contemporary single-center experience  
    Nathan DP, Brinster CJ, Woo EY, Carpenter JP, Fairman RM, Jackson MM, Journal of Vascular Surgery, 1/1/2011
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • A percutaneous aortic device for cerebral embolic protection during cardiovascular intervention.
    Carpenter JP, Carpenter JT, Tellez A, Webb JG, Yi GH, Granada JF, American College of Cardiology, 1/1/2010
  • The value of the initial post-EVAR CTA scan in predicting future secondary procedures.
    Patel MS, Carpenter JP, Society for Vascular Surgery, 1/1/2010
  • Results of the Powerlink suprarenal bifurcated device trial.
    Abai B, Carpenter JP, Society for Vascular Surgery, 1/1/2009
  • Join now to see all

Lectures

  • The Nellix system for endovascular aortic aneurysm repair. 
    New York, NY - 1/1/2011
  • The Surgeon as Inventor 
    Philadelphia, PA - 1/1/2011
  • The Nellix system for endovascular aortic aneurysm repair 
    Chicago, IL - 1/1/2011
  • Join now to see all

Other

  • Proper Technical Procedures Improved Outcomes in a Retrospective Analysis of EVAS FORWARD IDE Trial 3-Year Results 
    Jeffrey Carpenter, MD, Journal of Vascular Surgery
    https://www.doximity.com/articles/29ad1d63-72bb-4575-bf37-12292353d18f
    UpToDate, Wolters Kluwer Health - 2012-10-19
  • Abdominal aortic aneurysm: a silent killer. Episode 705, Healthy Body Healthy Mind Series 
    Carpenter JP, Information Television, Public Broadcasting System (PBS)
    1/1/2006
  • Acute arterial occlusion. Peripheral Vascular Disease Section 
    Carpenter JP, Up to date in medicine
    1/1/2006

Authored Content

  • Refinement of Anatomic Indications for the Nellix System for Endovascular Aneurysm Sealing Based on 2-Year Outcomes from the EVAS FORWARD IDE TrialMarch 2018

Press Mentions

  • Endologix, Inc. Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix® EndoVascular Aneurysm Sealing System
    Endologix, Inc. Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix® EndoVascular Aneurysm Sealing SystemMarch 5th, 2018
  • After Many Missteps, Endologix Makes Progress on Nellix
    After Many Missteps, Endologix Makes Progress on NellixMarch 5th, 2018
  • Endologix Presents Positive Two-Year Clinical Data from the Nellix® EVAS FORWARD IDE Trial
    Endologix Presents Positive Two-Year Clinical Data from the Nellix® EVAS FORWARD IDE TrialJune 3rd, 2017
  • Join now to see all

Professional Memberships